Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Belle Health vs PrideRx

Belle Health
Graded #48

Higher grade

vs+21.299999999999997
PrideRx
Graded #434

Lower grade

The verdict

Belle Health takes it — 77/100 to 55.7/100.

Belle Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Belle Health is a national DTC telehealth platform offering compounded semaglutide and tirzepatide with flat-rate pricing — the same monthly cost at every dose, with no escalation surcharge as you titrate up.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBelle Health +72
92
20
Dose & formulationPrideRx +11
72
83
Clinical oversightPrideRx +3
71
74
Labs & monitoringBelle Health +19
72
53
FulfillmentBelle Health +18
85
67
Contract termsBelle Health +14
55
41
Belle Health · left barPrideRx · right bar

The numbers

MetricBelle HealthPrideRx
WeighScore77/10055.7/100
GradeC+C
Scorecard rank#48#434
Semaglutide$119/mo$149/mo (starting dose, plus a separate fee, brand-name)
Tirzepatide$199/mo (all doses, 3-month plan, compounded)$299/mo (2.5 mg dose, plus a separate fee, brand-name)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Belle Health

Graded #48 · C+

Strengths

  • Five named compounding pharmacy partners disclosed (Striker, Strive, OptioRx, Enovex, Braun PharmaCare)
  • Flat-rate pricing — $119/mo semaglutide, $199/mo tirzepatide — doesn't rise at higher doses
  • Free weekly registered-dietitian sessions included
  • Operating since 2017
  • LegitScript Certified

Where it loses points

  • $199 tirzepatide price requires a 3-month bundle commitment
  • Compounded medications are not FDA-approved
  • Multi-pharmacy model — formulations may differ across orders
  • FDA issued this company a warning letter dated 20 February 2026; the letter is public in FDA's warning-letter database
PrideRx

Graded #434 · C

Strengths

  • All three brand-name GLP-1 options on one platform — Zepbound injection, Wegovy Pill, and Foundayo — no compounded substitutes
  • Medication ships from and is billed by LillyDirect or NovoCare; PrideRx never handles or re-sells the drug
  • Transparent published per-dose pricing with on-page verification dates
  • $99/mo membership includes doctor visits and prescription management; 24-hour prescription review

Where it loses points

  • $99/mo membership on top of medication cost — all-in runs $248–$548/mo depending on drug and dose
  • Legal entity and prescribing medical group are not named on the site
  • No LegitScript certification visible
  • State availability is not published — telehealth consult rules vary by state

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard